# Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain

> **NCT00720330** · NA · TERMINATED · sponsor: **The Cleveland Clinic** · enrollment: 12 (actual)

## Conditions studied

- Pain
- Nausea

## Interventions

- **DRUG:** ropivacaine
- **DRUG:** Lidocaine/Ketamine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00720330
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Enrollment challenges prohibited study progression.
- **Last updated:** 2019-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00720330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00720330, "Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00720330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*